BioWorld Science

June 1, 1998

View Archived Issues

Fujisawa: FY 1998 highlights

Read More

Pentoxifylline shows efficacy in treatment of pruritus in HIV-infected patients

Read More

Compounds for bone diseases, neuropathy discovered at Takeda

Read More

New protein farnesyltransferase inhibitors prepared by Zeneca

Read More

Company Profile: ImmPheron

Read More

Imutech and Harvard Medical School join forces for clotrimazole development

Read More

Steroidogenesis Inhibitors seeks Romanian approval to begin pediatric trial with Anticort

Read More

Novartis and Trega sign agreement for obesity and diabetes research

Read More

Inex: Q1 1998 highlights

Read More

Schering AG presents factor Xa/thrombin inhibitors

Read More

Protein tyrosine or serine/threonine kinase inhibitors in development at Novartis

Read More

Agents for tumors and tumor metastasis synthesized at Ishihara Sangyo

Read More

Pfizer reports AChE inhibitors with memory-enhancing effects

Read More

Integrilin launched in first market today

Read More

New topical corticosteroid available in U.S. for ophthalmic use

Read More

Muscarinic receptor ligands from AHP with potential in treating cognition disorders

Read More

MMP/TNF-alpha convertase inhibitors disclosed by Agouron

Read More

JTV-519, a novel cardioprotective agent, and propranolol protect myocardium following SAH

Read More

FDA approves ADCON-L

Read More

ECG and hemodynamic evaluation of dronedarone, a new antiarrhythmic agent

Read More

Alzheimer's disease treatment launched in U.K.

Read More

Emisphere Technologies begins phase II trial with oral heparin

Read More